Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ZEG.DE Stock Summary
Top 10 Correlated ETFs
ZEG.DE
In the News
ZEG.DE Financial details
Company Rating
Strong Buy
Market Cap
215.9B
Income
4.7B
Revenue
43.84B
Book val./share
23.1
Cash/share
4.17
Dividend
2.39
Dividend %
1.63%
Employees
83.5K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
48.24
Forward P/E
13.49
PEG
0.13
P/S
5.18
P/B
6.34
P/C
32.81
P/FCF
37.65
Quick Ratio
0.26
Current Ratio
0.9
Debt / Equity
1.7
LT Debt / Equity
0.77
-
-
EPS (TTM)
3.03
EPS next Y
10.14
EPS next Q
-
EPS this Y
2550%
EPS next Y
234.77%
EPS next 5Y
234.77%
EPS last 5Y
4.51%
Revenue last 5Y
14.96%
Revenue Q/Q
-2.93%
EPS Q/Q
100%
-
-
-
-
SMA20
-
SMA50
8.8%
SMA100
3.03%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
13%
ROC
0.06%
Gross Margin
75%
Oper. Margin
9%
Profit Margin
11%
Payout
94%
Shs Outstand
1.55B
Shs Float
1.54B
-
-
-
-
Target Price
-
52W Range
109.35-140.45
52W High
-2.29%
52W Low
+25.5%
RSI
54
Rel Volume
0.22
Avg Volume
6.27K
Volume
1.37K
Perf Week
2.32%
Perf Month
2.24%
Perf Quarter
6.92%
Perf Half Y
4.79%
-
-
-
-
Beta
0.178723
-
-
Volatility
1.1%, 1.64%
Prev Close
0.04%
Price
136.8
Change
0.44%
ZEG.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 17.43 | 18.74 | 20.29 | 26.39 | 28.65 | |
Net income per share | 1.7 | 1.03 | 2.44 | 0.08 | 2.12 | |
Operating cash flow per share | 2.07 | 2.28 | 3.66 | 4.21 | 6.34 | |
Free cash flow per share | 0.98 | 0.39 | 1.67 | 2.65 | 4.68 | |
Cash per share | 4.38 | 4.78 | 6.09 | 4.51 | 4.14 | |
Book value per share | 9.84 | 10.09 | 11.91 | 27.69 | 23.93 | |
Tangible book value per share | -15.49 | -13.76 | -13.07 | -16.29 | -14.26 | |
Share holders equity per share | 9.84 | 10.09 | 11.91 | 27.69 | 23.93 | |
Interest debt per share | 16.16 | 15.11 | 16.53 | 22.62 | 19.75 | |
Market cap | 96.07B | 132.41B | 133.78B | 166.31B | 209.65B | |
Enterprise value | 110.44B | 145.26B | 146.33B | 190.76B | 232.71B | |
P/E ratio | 44.58 | 99.18 | 41.86 | 1.48K | 63.76 | |
Price to sales ratio | 4.35 | 5.43 | 5.03 | 4.44 | 4.73 | |
POCF ratio | 36.7 | 44.6 | 27.88 | 27.89 | 21.37 | |
PFCF ratio | 77.04 | 260.13 | 61 | 44.2 | 28.97 | |
P/B Ratio | 7.71 | 10.09 | 8.56 | 4.24 | 5.66 | |
PTB ratio | 7.71 | 10.09 | 8.56 | 4.24 | 5.66 | |
EV to sales | 5 | 5.96 | 5.5 | 5.1 | 5.25 | |
Enterprise value over EBITDA | 15.3 | 20.7 | 17.48 | 25.22 | 24.95 | |
EV to operating cash flow | 42.18 | 48.93 | 30.49 | 31.99 | 23.73 | |
EV to free cash flow | 88.56 | 285.39 | 66.72 | 50.69 | 32.16 | |
Earnings yield | 0.02 | 0.01 | 0.02 | 0 | 0.02 | |
Free cash flow yield | 0.01 | 0 | 0.02 | 0.02 | 0.03 | |
Debt to equity | 3.74 | 3.56 | 3.27 | 1.68 | 1.6 | |
Debt to assets | 0.77 | 0.76 | 0.77 | 0.63 | 0.62 | |
Net debt to EBITDA | 1.99 | 1.83 | 1.5 | 3.23 | 2.47 | |
Current ratio | 0.96 | 0.86 | 0.96 | 1.16 | 0.86 | |
Interest coverage | 1.11 | 2.04 | 3.95 | 0.81 | 2.79 | |
Income quality | 1.21 | 1.92 | 1.23 | -22.5 | 3.92 | |
Dividend Yield | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | |
Payout ratio | 1.62 | 2.69 | 1.12 | 34.43 | 1.33 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.27 | 0.24 | 0.23 | 0.26 | 0.22 | |
Intangibles to total assets | 0.56 | 0.53 | 0.49 | 0.59 | 0.61 | |
Capex to operating cash flow | -0.52 | -0.83 | -0.54 | -0.37 | -0.26 | |
Capex to revenue | -0.06 | -0.1 | -0.1 | -0.06 | -0.06 | |
Capex to depreciation | -0.37 | -0.65 | -0.83 | -0.34 | -0.47 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 19.41 | 15.26 | 25.55 | 7.02 | 33.81 | |
ROIC | 0.03 | 0.06 | 0.12 | -0.01 | 0.08 | |
Return on tangible assets | 0.08 | 0.05 | 0.09 | 0 | 0.09 | |
Graham Net | -31.26 | -29.95 | -31.32 | -38.92 | -32.73 | |
Working capital | -701M | -2.55B | -763M | 3.65B | -3.7B | |
Tangible asset value | -19.62B | -17.91B | -17.15B | -23.1B | -22.07B | |
Net current asset value | -31.02B | -31.22B | -31.55B | -39.83B | -36.83B | |
Invested capital | 1.53 | 1.39 | 1.3 | 0.78 | 0.79 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 2.67B | 7.85B | 14.89B | 17.36B | 18.99B | |
Average inventory | 2.96B | 3.04B | 3.61B | 6.5B | 6.84B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 127.19 | 1.04K | 1.09K | 555.79 | 560.86 | |
Days of inventory on hand | 213.71 | 236.83 | 277.18 | 263.63 | 138.42 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 2.87 | 0.35 | 0.34 | 0.66 | 0.65 | |
Inventory turnover | 1.71 | 1.54 | 1.32 | 1.38 | 2.64 | |
ROE | 0.17 | 0.1 | 0.2 | 0 | 0.09 | |
Capex per share | -1.08 | -1.89 | -1.99 | -1.55 | -1.66 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 7.36 | 6.95 | 7.09 | 7.23 | 7.02 | |
Net income per share | 0.25 | 0.23 | 1.06 | 0.58 | 1.16 | |
Operating cash flow per share | 2.09 | 0.81 | 1.89 | 1.55 | 2.02 | |
Free cash flow per share | 1.85 | 0.46 | 1.18 | 1.19 | 1.07 | |
Cash per share | 3.76 | 3.15 | 3.16 | 4.13 | 4.17 | |
Book value per share | 23.48 | 23.2 | 22.7 | 23.91 | 23.1 | |
Tangible book value per share | -16.07 | -15.35 | -15.59 | -14.25 | -15.16 | |
Share holders equity per share | 23.48 | 23.2 | 22.7 | 23.91 | 23.1 | |
Interest debt per share | 20.31 | 19.26 | 19.15 | 19.1 | 20.57 | |
Market cap | 205.73B | 203.83B | 172.48B | 209.78B | 217.39B | |
Enterprise value | 231.07B | 228.55B | 197.32B | 232.85B | 242.66B | |
P/E ratio | 133.25 | 141.55 | 26.29 | 58.21 | 30.14 | |
Price to sales ratio | 18.06 | 18.92 | 15.71 | 18.72 | 19.98 | |
POCF ratio | 63.65 | 163.33 | 58.87 | 87.48 | 69.39 | |
PFCF ratio | 71.71 | 289.13 | 94.82 | 113.76 | 130.72 | |
P/B Ratio | 5.66 | 5.67 | 4.91 | 5.66 | 6.07 | |
PTB ratio | 5.66 | 5.67 | 4.91 | 5.66 | 6.07 | |
EV to sales | 20.29 | 21.22 | 17.97 | 20.78 | 22.31 | |
Enterprise value over EBITDA | 105.13 | 119.35 | 71.52 | 204.61 | 62.41 | |
EV to operating cash flow | 71.49 | 183.13 | 67.34 | 97.1 | 77.45 | |
EV to free cash flow | 80.54 | 324.18 | 108.48 | 126.27 | 145.92 | |
Earnings yield | 0 | 0 | 0.01 | 0 | 0.01 | |
Free cash flow yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 1.76 | 1.69 | 1.68 | 1.6 | 1.7 | |
Debt to assets | 0.64 | 0.63 | 0.63 | 0.62 | 0.63 | |
Net debt to EBITDA | 11.53 | 12.9 | 9 | 20.27 | 6.5 | |
Current ratio | 1 | 0.96 | 0.81 | 0.86 | 0.9 | |
Interest coverage | 2.61 | 1.73 | 3.67 | -0.95 | 6.98 | |
Income quality | 5.84 | 5.05 | 3.17 | 3.08 | 1.39 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Payout ratio | 7.7 | 0 | 0.85 | 0 | 1.69 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.19 | 0.24 | 0.21 | 0.23 | 0.24 | |
Intangibles to total assets | 0.61 | 0.62 | 0.63 | 0.61 | 0.61 | |
Capex to operating cash flow | -0.11 | -0.44 | -0.38 | -0.23 | -0.47 | |
Capex to revenue | -0.03 | -0.05 | -0.1 | -0.05 | -0.14 | |
Capex to depreciation | -0.28 | -0.4 | -0.83 | -0.37 | -0.98 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 11.48 | 11.01 | 23.26 | 17.69 | 24.6 | |
ROIC | 0.01 | 0.01 | 0.03 | -0.01 | 0.03 | |
Return on tangible assets | 0.01 | 0.01 | 0.05 | 0.02 | 0.05 | |
Graham Net | -35.06 | -33.98 | -33.33 | -32.71 | -33.53 | |
Working capital | -93M | -898M | -4.63B | -3.7B | -2.59B | |
Tangible asset value | -24.87B | -23.77B | -24.14B | -22.07B | -23.48B | |
Net current asset value | -41.27B | -39.71B | -38.81B | -36.83B | -38.61B | |
Invested capital | 0.86 | 0.82 | 0.83 | 0.79 | 0.88 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 18.4B | 17.84B | 17.76B | 18.37B | 19.13B | |
Average inventory | 8.3B | 6.92B | 5.65B | 4.89B | 4.83B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 457.92 | 534.99 | 534.02 | 590.9 | 907.56 | |
Days of inventory on hand | 195.43 | 186.72 | 153.26 | 145.83 | 234.66 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.2 | 0.17 | 0.17 | 0.15 | 0.1 | |
Inventory turnover | 0.46 | 0.48 | 0.59 | 0.62 | 0.38 | |
ROE | 0.01 | 0.01 | 0.05 | 0.02 | 0.05 | |
Capex per share | -0.23 | -0.35 | -0.72 | -0.36 | -0.95 |
ZEG.DE Frequently Asked Questions
What is AstraZeneca PLC stock symbol ?
AstraZeneca PLC is a GB stock and trading under the symbol ZEG.DE
What is AstraZeneca PLC stock quote today ?
AstraZeneca PLC stock price is $136.8 today.
Is AstraZeneca PLC stock public?
Yes, AstraZeneca PLC is a publicly traded company.